A detailed history of Novem Group transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Novem Group holds 495 shares of TMO stock, worth $276,205. This represents 0.03% of its overall portfolio holdings.

Number of Shares
495
Previous 647 23.49%
Holding current value
$276,205
Previous $322 Million 37.65%
% of portfolio
0.03%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 16, 2025

SELL
$390.26 - $489.06 $59,319 - $74,337
-152 Reduced 23.49%
495 $201 Million
Q1 2025

Apr 28, 2025

BUY
$497.6 - $606.74 $38,812 - $47,325
78 Added 13.71%
647 $322 Million
Q4 2024

Feb 14, 2025

BUY
$501.29 - $612.85 $285,234 - $348,711
569 New
569 $296 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $219B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Novem Group Portfolio

Follow Novem Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novem Group, based on Form 13F filings with the SEC.

News

Stay updated on Novem Group with notifications on news.